Status: Recruiting
Advanta VXT and Flixene PMCF Registry
The purpose of the registry is to evaluate the long-term safety and performance of Advanta VXT and Flixene vascular grafts for repair or replacement of peripheral arteries. This registry is also intended to provide further data on the clinical usefulness of the Advanta VXT and Flixene vascular grafts.
Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Atrium Medical CorporationUpdated: Sep 11, 2026Locations: 2
Eligibility criteria
Willing, and able to provide legally-effective written informed consent (as requ... [+3]